FDA Amends Animal Drug Regulations to Withdraw Approval of Certain NADA's

Summary

The FDA is removing provisions from its animal drug regulations that approved new animal drug applications (NADA's) held by Parke-Davis, Akorn, Inc., and Veterinary Research and Development, Inc., following written requests from the sponsors to withdraw approval.